Martingale Asset Management’s Omega Protein OME Stock Holding History

Martingale Asset Management’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-101,008	Closed	-$1.68M	–	1027
2017 Q3	$1.68M	Sell	101,008 -40,526	-29%	-$659K	0.02%	593
2017 Q2	$2.53M	Hold	141,534	–	–	0.04%	483
2017 Q1	$2.84M	Buy	+141,534	New	+$3.3M	0.04%	444
2014 Q4	–	Sell	-76,930	Closed	-$962K	–	912
2014 Q3	$962K	Buy	+76,930	New	+$1.07M	0.03%	506
2013 Q4	–	Sell	-76,040	Closed	-$774K	–	1064
2013 Q3	$774K	Buy	76,040 +18,700	+33%	+$175K	0.03%	628
2013 Q2	$515K	Buy	+57,340	New	+$578K	0.02%	732

Martingale Asset Management's OME Position: Q4 2017 in Review

Martingale Asset Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 101,008 shares — an estimated $1.68M sold.

Martingale Asset Management first reported a position in OME in Q2 2013 and held it in 6 quarters. The position peaked at $2.84M in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

Martingale Asset Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
Martingale Asset Management sold 101,008 Omega Protein shares in Q4 2017, an estimated $1.68M.
Martingale Asset Management first reported a position in Omega Protein in Q2 2013 and held it in 6 quarters.
Martingale Asset Management's Omega Protein position peaked at $2.84M in Q1 2017.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Martingale Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.